In the tumor microenvironment, CD74 also acts as a regulator of tumor‐infiltrating regulatory T cells (Tregs) by modulating their accumulation and function.[19, 20] By interfering with Treg‐mediated immune suppression, CD74 represents a promising therapeutic target, providing a novel approach to enhance antitumor immunity in PSCC. Here, CD74 is linked to neoplasm.